IMA Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$133K Buy
145
+1
+0.7% +$1.01K 0.01% 191
2025
Q4
$155K Buy
144
+24
+20% +$22.9K 0.01% 186
2025
Q3
$91.6K Buy
120
+41
+52% +$30.5K 0.01% 196
2025
Q2
$61.6K Buy
79
+12
+18% +$9.32K 0.01% 217
2025
Q1
$55.3K Buy
+67
New +$55.8K 0.01% 228
2024
Q4
Sell
-39
Closed -$34.6K 233
2024
Q3
$34.6K Buy
+39
New +$35.1K 0.01% 198
2022
Q4
Sell
-2
Closed -$1K 398
2022
Q3
$1K Buy
+2
New +$634 ﹤0.01% 312
2020
Q4
Sell
-13
Closed -$2K 303
2020
Q3
$2K Buy
+13
New +$2.01K ﹤0.01% 267
2019
Q1
Sell
-1
Closed 311
2018
Q4
$0 Hold
1
﹤0.01% 336
2018
Q3
$0 Hold
1
﹤0.01% 407
2018
Q2
$0 Buy
+1
New +$82 ﹤0.01% 473

Other funds holding LLY

IMA Advisory Services's LLY Position: Q1 2026 in Review

IMA Advisory Services increased its Eli Lilly (LLY) stake by 0.69% in Q1 2026, buying an estimated $1.01K and bringing the position to 145 shares worth $133K. The position accounts for 0.01% of the portfolio, ranked #191.

IMA Advisory Services first reported a position in LLY in Q2 2018 and has held it in 11 quarters since. The position peaked at $155K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • IMA Advisory Services held 145 shares of Eli Lilly worth $133K as of Q1 2026.
  • IMA Advisory Services bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.01% of IMA Advisory Services's portfolio in Q1 2026, its #191 holding.
  • IMA Advisory Services first reported a position in Eli Lilly in Q2 2018 and has held it in 11 quarters since.
  • IMA Advisory Services's Eli Lilly position peaked at $155K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.